Friday July 19, 2019 0 comments
WESTMINSTER -- Flagship Biosciences, an advanced tissue data services company, announced the addition of Meredith James to its executive team as VP of operations.
Flagship said James brings a wealth of experience gained in more than 20 years in drug development. In her new role, James is responsible for ensuring on-time delivery of all projects by overseeing the overall day-to-day operations of Flagship’s services.
With a career that spans laboratory operations and clinical program and project management, James most recently led translational programs at Precision for Medicine. She previously held leadership positions at PPD Laboratories and Quintiles (now part of IQVIA) where she helped to develop, manage, and organize processes and vendor relationships.
James also has years of experience in laboratory, IT, and account and project management that make her uniquely suited to the new role, Flagship said.
“I am pleased to have Ms. James join our diverse and distinguished team here at Flagship,” said Trevor Johnson, Flagship Biosciences CEO.
“Ms. James’ leadership in pharmaceutical development services, as well as her experience in building effective partnerships, will support the transformation of our current team into a scalable, high-growth organization."
“It is a very exciting time to join the Flagship Biosciences team,” said James. “I am thrilled to be able to collaborate within what is already an exceptional operations department.
“I look forward to growing and scaling the team to meet the demands of the market.”